Table 3

Glycemic control

Intervention groupnControl groupnP valueDifferenceP value
Baseline
 % HbA1c8.46 (1.30)103 (99%)8.61 (1.57)99 (98%)
 mmol/mol69 (14.2)71 (17.2)
Intervention period (0–18 months)
 % HbA1c8.59 (1.47)63 (61%)8.63 (1.49)50 (50%)0.758
 mmol/mol70 (16.1)71 (16.3)
Follow-up period (18–24 months)
 % HbA1c8.33 (1.21)73 (70%)8.80 (1.55)71 (70%)0.057
 mmol/mol68 (13.2)73 (16.9)
Change from baseline
Intervention period (0–18 months)
 % HbA1c−0.20 (1.24)−0.19 (1.29)−0.04 (−0.49, 0.40)0.848
 mmol/mol−2.20 (13.6)−2.10 (14.1)−0.40 (−5.40, 4.40)
Change from baseline
Follow-up period (18–24 months)
 % HbA1c0.03 (1.09)*−0.28 (1.64)0.37 (−0.04, 0.78)*0.073
 mmol/mol0.30 (11.9)*−3.10 (17.9)4.00 (−4.40, 8.50)*
  • Data are mean (SD), n (%), or difference (95% CI). The difference is based on ANCOVA adjusted for baseline HbA1c and site. HbA1c represents central laboratory value.

  • *Positive difference depicts decrease (improvement) from the baseline HbA1c value.